Improved ataxia telangiectasia mutated kinase inhibitor KU60019 provides a promising treatment strategy for non-invasive breast cancer

It has previously been reported that KU60019, as a highly effective radiosensitizer, inhibits the DNA damage response and blocks radiation-induced phosphorylation of key ataxia telangiectasia mutated targets in human glioma cells. The present study investigated whether KU60019 affects cell physiolog...

Descripción completa

Detalles Bibliográficos
Autores principales: ZHU, YING, MAO, CHANGFEI, WU, JIANZHONG, LI, SHUCHUN, MA, RONG, CAO, HAIXIA, JI, MINGHUA, JING, CHANGWEN, TANG, JINHAI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186532/
https://www.ncbi.nlm.nih.gov/pubmed/25289090
http://dx.doi.org/10.3892/ol.2014.2444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186532/
https://www.ncbi.nlm.nih.gov/pubmed/25289090
http://dx.doi.org/10.3892/ol.2014.2444

Ejemplares similares